Sage Therapeutics, Inc. (SAGE) Social Stream



Sage Therapeutics, Inc. (SAGE): $49.82

0.26 (+0.52%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add SAGE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#179 of 380

in industry

SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts

Use the tables below to see what analysts covering SAGE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 20 $105 $48 $73.368 $49.56 48.04%
2021-12-20 20 $105 $48 $72.842 $49.56 46.98%
2022-01-12 19 $105 $48 $73.157 $49.56 47.61%
2022-01-26 17 $105 $48 $73.157 $49.56 47.61%
2022-02-16 17 $105 $48 $72.315 $49.56 45.91%
2022-02-25 18 $105 $48 $71.736 $49.56 44.75%
2022-02-28 17 $105 $48 $70.055 $49.56 41.35%
2022-03-21 17 $105 $40 $68.722 $49.56 38.66%
2022-04-01 18 $105 $37 $67.052 $49.56 35.29%
2022-05-03 18 $105 $37 $67.21 $49.56 35.61%
2022-05-04 18 $105 $37 $65.7 $49.56 32.57%
2022-05-06 18 $105 $37 $64.631 $49.56 30.41%
2022-05-10 18 $105 $37 $64.421 $49.56 29.99%
2022-05-24 19 $105 $37 $64.85 $49.56 30.85%
2022-06-01 19 $105 $37 $65 $49.56 31.15%
2022-06-13 18 $105 $36 $63.5 $49.56 28.13%
2022-07-21 18 $105 $36 $61 $49.56 23.08%
2022-08-03 18 $105 $36 $57.941 $49.56 16.91%
2022-08-04 18 $105 $36 $59.611 $49.56 20.28%
2022-09-19 18 $105 $36 $59.5 $49.56 20.06%
2022-10-17 16 $105 $36 $59.5 $49.56 20.06%
2022-11-01 16 $105 $36 $59.111 $49.56 19.27%
2022-11-08 17 $105 $36 $59.111 $49.56 19.27%
2022-11-11 18 $105 $36 $57 $49.56 15.01%
2022-11-21 19 $105 $36 $56.85 $49.56 14.71%
2022-12-07 20 $105 $36 $55 $49.56 10.98%
2023-02-06 20 $105 $36 $55.3 $49.56 11.58%
2023-02-17 20 $105 $36 $55.5 $49.56 11.99%
2023-02-21 21 $105 $36 $56.05 $49.56 13.1%
2023-03-10 21 $105 $36 $56.1 $49.56 13.2%
2023-03-13 22 $105 $36 $56.285 $49.56 13.57%
2023-05-03 22 $105 $36 $57.65 $49.56 16.32%
2023-05-04 22 $105 $40 $57.8 $49.56 16.63%
2023-05-09 22 $105 $40 $56.894 $49.56 14.8%
2023-05-22 21 $105 $40 $56.947 $49.56 14.91%

The Trend in the Analyst Price Target


Over the past 16 months, SAGE's average price target has gone down $15.41.

Over the past 49 weeks, SAGE's average upside potential has been 43.17%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-13 18 105 36 63.500 32.00 98.44%
2022-09-10 18 105 36 59.500 42.00 41.67%
2023-03-10 21 105 36 56.100 39.56 41.81%
2023-05-09 22 105 40 56.894 50.66 12.31%
2023-05-22 22 105 40 56.947 53.38 6.68%

SAGE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.18 8 2 12 0 0 22

The Trend in the Broker Recommendations


Over the past 14 months, SAGE's average broker recommendation rating worsened by 0.06.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SAGE as an investment opportunity.

  • In terms of how SAGE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 4578% of that group.
  • SAGE has a lower variance in analysts' estimates than -4328.44% of stocks in the mid market cap category.
  • In the context of Pharmaceutical Products stocks, SAGE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1015.03% of them.
  • SAGE has a higher average analyst price target than 3796.94% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, FGEN, TARO, and ITCI are the three stocks most similar to SAGE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is SAGE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7263 seconds.